128
Views
5
CrossRef citations to date
0
Altmetric
Hematological Malignancy

Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells

&
Pages 139-144 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Geylani Can, Huseyin Atakan Ekiz & Yusuf Baran. (2011) Imatinib induces autophagy through BECLIN‐1 and ATG5 genes in chronic myeloid leukemia cells. Hematology 16:2, pages 95-99.
Read now

Articles from other publishers (4)

EunSook KimMichiko MatsuseVladimir SaenkoKeiji SuzukiAkira OhtsuruNorisato MitsutakeShunichi Yamashita. (2012) Imatinib Enhances Docetaxel-Induced Apoptosis Through Inhibition of Nuclear Factor-κB Activation in Anaplastic Thyroid Carcinoma Cells. Thyroid 22:7, pages 717-724.
Crossref
Marta Świtalska, Anna Nasulewicz-Goldeman, Aleksandra Opolska, Magdalena Maciejewska, Andrzej Kutner & Joanna Wietrzyk. (2012) The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells. Anti-Cancer Drugs 23:1, pages 70-80.
Crossref
Zeynep Cakir, Guray Saydam, Fahri Sahin & Yusuf Baran. (2010) The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells. Journal of Cancer Research and Clinical Oncology 137:2, pages 279-286.
Crossref
Paula Kinsella, Martin Clynes & Verena Amberger-Murphy. (2010) Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay. Journal of Neuro-Oncology 101:2, pages 189-198.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.